256
Views
7
CrossRef citations to date
0
Altmetric
Original Investigations

5-HT2A receptor-mediated Gαq/11 activation in psychiatric disorders: A postmortem study

ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon
Pages 505-515 | Received 15 Aug 2020, Accepted 12 Oct 2020, Published online: 09 Nov 2020

References

  • Arora RC, Meltzer HY. 1989. Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry. 146:730–736.
  • Aznar S, Hervig ME-S. 2016. The 5-HT2A serotonin receptor in executive function: implications for neuropsychiatric and neurodegenerative diseases. Neurosci Biobehav Rev. 64:63–82.
  • Barnes NM, Sharp T. 1999. A review of central 5-HT receptors and their function. Neuropharmacology. 38:1083–1152.
  • Bachmann S. 2018. Epidemiology of suicide and the psychiatric perspective. IJERPH. 15:1425.
  • Bohn LM, Schmid CL. 2010. Serotonin receptor signaling and regulation via β-arrestins. Crit Rev Biochem Mol Biol. 45:555–566.
  • Boulougouris V, Malogiannis I, Lockwood G, Zervas I, Di Giovanni G. 2013. Serotonergic modulation of suicidal behaviour: integrating preclinical data with clinical practice and psychotherapy. Exp Brain Res. 230:605–624.
  • Cheetham SC, Crompton MR, Katona CL, Horton RW. 1988. Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res. 443:272–280.
  • Dean B, Crossland N, Boer S, Scarr E. 2008. Evidence for altered post-receptor modulation of the serotonin 2a receptor in schizophrenia. Schizophr Res. 104:185–197.
  • Friedman E, Wang HY. 1996. Receptor-mediated activation of G proteins is increased in postmortem brains of bipolar affective disorder subjects. J Neurochem. 67:1145–1152.
  • García-Bea A, Miranda-Azpiazu P, Muguruza C, Marmolejo-Martinez-Artesero S, Diez-Alarcia R, Gabilondo AM, Callado LF, Morentin B, González-Maeso J, Meana JJ. 2019. Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via Gαi1-proteins. Eur Neuropsychopharmacol. 29:1453–1463.
  • Gray JA, Roth BL. 2001. Paradoxical trafficking and regulation of 5-HT2A receptors by agonists and antagonists. Brain Res Bull. 56:441–451.
  • Guiard BP, Di Giovanni G. 2015. Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link? Front Pharmacol. 6:46.
  • Harrison C, Traynor JR. 2003. The [35S]GTPgammaS binding assay: approaches and applications in pharmacology. Life Sci. 74:489–508.
  • Jope RS, Song L, Li PP, Song L, Li PP, Young LT, Kish SJ, Pacheco MA, Warsh JJ. 1996. The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain. J Neurochem. 66:2402–2409.
  • Kang K, Huang XF, Wang Q, Deng C. 2009. Decreased density of serotonin 2A receptors in the superior temporal gyrus in schizophrenia – a postmortem study. Prog Neuropsychopharmacol Biol Psychiatry. 33:867–871.
  • Nikolaus S, Müller H-W, Hautzel H. 2016. Different patterns of 5-HT receptor and transporter dysfunction in neuropsychiatric disorders-a comparative analysis of in vivo imaging findings. Rev Neurosci. 27:27–59.
  • Odagaki Y. 2019. Guanosine‐5′‐O‐(3‐[35S]thio)triphosphate ([35S]GTPγS) binding/immunoprecipitation assay using magnetic beads coated with anti‐Gα antibody in mammalian brain membranes. In: Odagaki Y, Borroto‐Escuela DO, editors. Co‐immunoprecipitation methods for brain tissue. Vol. 144. Neuromethods. New York (NY): Springer Nature; p. 97–108.
  • Odagaki Y, Toyoshima R. 2013. Activation of Gq proteins coupled with 5-HT2 receptors in rat cerebral cortical membranes assessed by antibody-capture scintillation proximity assay/[35S]GTPγS binding. Pharmacology. 92:2–10.
  • Odagaki Y, Kinoshita M, Toyoshima R. 2014. Functional activation of Gαq via serotonin2A (5-HT2A) and muscarinic acetylcholine M1 receptors assessed by guanosine-5׳-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding/immunoprecipitation in rat brain membranes. Eur J Pharmacol. 726:109–115.
  • Odagaki Y, Kinoshita M, Ota T, Meana JJ, Callado LF, García-Sevilla JA. 2017. Functional activation of Gαq coupled to 5-HT2A receptor and M1 muscarinic acetylcholine receptor in postmortem human cortical membranes. J Neural Transm (Vienna). 124:1123–1133.
  • Odagaki Y, Kinoshita M, Meana JJ, Callado LF, García-Sevilla JA. 2020. Functional coupling of M1 muscarinic acetylcholine receptor to Gαq/11 in dorsolateral prefrontal cortex from patients with psychiatric disorders: a postmortem study. Eur Arch Psychiatry Clin Neurosci. 270:869–880.
  • Oquendo MA, Russo SA, Underwood MD, Kassir SA, Ellis SP, Mann JJ, Arango V. 2006. Higher postmortem prefrontal 5-HT2A receptor binding correlates with lifetime aggression in suicide. Biol Psychiatry. 59:235–243.
  • Pandey GN. 2013. Biological basis of suicide and suicidal behavior. Bipolar Disord. 15:524–541.
  • Raymond JR, Mukhin YV, Gelasco A, Turner J, Collinsworth G, Gettys TW, Grewal JS, Garnovskaya MN. 2001. Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther. 92:179–212.
  • Rosel P, Arranz B, San L, Vallejo J, Crespo JM, Urretavizcaya M, Navarro MA. 2000. Altered 5-HT2A binding sites and second messenger inositol trisphosphate (IP3) levels in hippocampus but not in frontal cortex from depressed suicide victims. Psychiatry Res. 99:173–181.
  • Rosel P, Arranz B, Urretavizcaya M, Oros M, San L, Navarro MA. 2004. Altered 5-HT2A and 5-HT4 postsynaptic receptors and their intracellular signalling systems IP3 and cAMP in brains from depressed violent suicide victims. Neuropsychobiology. 49:189–195.
  • Selvaraj S, Arnone D, Cappai A, Howes O. 2014. Alterations in the serotonin system in schizophrenia: a systematic review and meta-analysis of postmortem and molecular imaging studies. Neurosci Biobehav Rev. 45:233–245.
  • Stockmeier CA. 2003. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatr Res. 37:357–373.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.